Closed sjspielman closed 2 years ago
@jharenza I've marked this as a draft PR since I imagine we'll have some back-and-forth about the figure conceptualization here. But, it's ready for you to have a look (just not "formal" review!).
Update - added one more plot as an option to consider. This barplot shows the fractions of characterized cell types, similar to the barplot I had made for molecular signature fractions.
I've updated this code based on some feedback from @jharenza and I feel this is ready for review now! Note that the code is now in a notebook inside the immune-deconv
module for improved organization, so in the end (probably a separate PR) we can copy final figures over into the main figures/
directory.
I suggest we proceed with survival analysis (again, note that given lack of variation in CD8+ scores, this is not likely going to be a useful predictor, but we'll find out!) in a subsequent PR and in its own notebook potentially in the survival-analysis/
module.
Noting that I also updated the analysis README to describe this notebook and its output.
This PR is continued from #1232.
Adds two visualizations that explore the cell type fractions estimated by
quanTIseq
across molecular subtypes from three different cancer groups: High-grade glioma astrocytoma, Ependymoma, Medulloblastoma. Unclassified subtypes and subtypes with <3 samples are not considered.Two visualization options are included - the data is the same but the faceting is flipped. Note that one of the versions contains fractions of uncharacterized cell types, which doesn't fit (due to faceting scheme) in the other version. Points are currently colored by cancer group.
Is the analysis in a mature enough form that the resulting figure(s) and/or table(s) are ready for review?
Yes
Questions for reviewers
04
figures script.Results
What types of results are included (e.g., table, figure)?
Two figures: version 1 and version 2
What is your summary of the results?
Reproducibility Checklist
Documentation Checklist
README
and it is up to date.analyses/README.md
and the entry is up to date.